Paclitaxel and Carboplatin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Paclitaxel and Carboplatin, covering 2018-12-04 to 2020-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 3]